Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT

Daisuke Nakamura1,2, Yasuhide Motoyoshi3,4, Shinya Nagaoka3,4

  • 1Department of Radiological Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; dai-naka@nagasaki-u.ac.jp.

Anticancer Research
|June 29, 2026
PubMed
Summary

The albumin-bilirubin (ALBI) grade and Child-Pugh classification independently predict survival in hepatocellular carcinoma (HCC) patients undergoing stereotactic body radiotherapy (SBRT). Combining ALBI and Child-Pugh offers a more comprehensive prognostic assessment for HCC treatment.

Related Concept Videos